Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M99.8Revenue (TTM) $M1.7Net Margin (%)-1,177.2Altman Z-Score-5.3
Enterprise Value $M66.5EPS (TTM) $-0.7Operating Margin %-1,189.5Piotroski F-Score2
P/E(ttm)--Beneish M-Score7.3Pre-tax Margin (%)-1,186.7Higher ROA y-yN
Price/Book3.810-y EBITDA Growth Rate %--Quick Ratio8.6Cash flow > EarningsY
Price/Sales51.25-y EBITDA Growth Rate %--Current Ratio8.6Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %-359.5ROA % (ttm)-65.2Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-91.5Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M34.2ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with PSDV

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PSDVKen Fisher 2015-09-30 Buy $3.49 - $4.47
($3.92)
$ 2.92-26%New holding12,057
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PSDV is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


PSDV: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Ross Leonard SVice President, Finance 2016-01-04Sell5,000$4.7-37.87view
Ross Leonard SVice President, Finance 2015-12-22Sell33,950$5.39-45.83view
Ashton PaulPresident & CEO 2015-12-22Sell120,000$5.39-45.83view
Ross Leonard SVice President, Finance 2015-12-01Sell1,050$4.06-28.08view
Ross Leonard SVice President, Finance 2015-08-03Sell5,000$4.05-27.9view
Ashton PaulPresident & CEO 2014-10-01Sell10,000$4.27-31.62view
Ashton PaulPresident & CEO 2014-09-02Sell10,000$4.78-38.91view
Ashton PaulPresident & CEO 2014-08-01Sell10,000$4.37-33.18view
Ashton PaulPresident & CEO 2014-07-01Sell10,000$4.32-32.41view
Ashton PaulPresident & CEO 2014-06-19Sell7,000$4-27view

Quarterly/Annual Reports about PSDV:

    News about PSDV:

    Articles On GuruFocus.com
    Weekly CEO Sales Highlight: pSivida Corp., Equity Residential, Ciena Corp., Sabre Corp. Dec 28 2015 
    pSivida Ltd. Reports Operating Results (10-Q) Feb 10 2011 
    pSivida Ltd. Reports Operating Results (10-Q) Nov 09 2010 
    pSivida Ltd. Reports Operating Results (10-K) Sep 27 2010 
    pSivida Ltd. Reports Operating Results (10-Q) May 13 2010 
    pSivida Ltd. Reports Operating Results (10-Q) Feb 12 2010 
    pSivida Ltd. Reports Operating Results (10-Q) Nov 13 2009 
    pSivida Ltd. Reports Operating Results (10-K) Sep 25 2009 
    pSivida Ltd. Reports Operating Results (10-Q) May 13 2009 
    pSivida Ltd. Reports Operating Results (10-Q) Feb 11 2009 

    More From Other Websites
    PSIVIDA CORP. Financials May 13 2016
    pSivida Corp. :PSDV-US: Earnings Analysis: Q3, 2016 By the Numbers May 12 2016
    PSIVIDA CORP. Files SEC form 10-Q, Quarterly Report May 06 2016
    PSivida reports 3Q loss May 05 2016
    PSivida reports 3Q loss May 05 2016
    pSivida Corp. Provides Company Update and Reports Third Quarter FY 2016 Results May 05 2016
    PSIVIDA CORP. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... May 05 2016
    pSivida Corp. Provides Company Update and Reports Third Quarter FY 2016 Results May 05 2016
    Q3 2016 pSivida Corp Earnings Release - After Market Close May 05 2016
    pSivida CEO to Present at 2016 International Symposium of Ocular Pharmacology and Therapeutics May 04 2016
    pSivida CEO to Present at 2016 International Symposium of Ocular Pharmacology and Therapeutics May 04 2016
    pSivida's Medidur for Posterior Uveitis Granted Orphan Drug Designation in Europe May 02 2016
    pSivida’s Medidur for Posterior Uveitis Granted Orphan Drug Designation in Europe May 02 2016
    pSivida Corp. Announces Third Quarter Fiscal Year 2016 Financial Results Release Date and Conference... Apr 27 2016
    pSivida Corp. Announces Third Quarter Fiscal Year 2016 Financial Results Release Date and Conference... Apr 27 2016
    pSivida to Present at the Sidoti Spring 2016 Emerging Growth Convention Mar 24 2016
    pSivida Corp. Earnings Analysis: Q2, 2016 By the Numbers Feb 11 2016
    PSIVIDA CORP. Files SEC form 8-K, Change in Directors or Principal Officers Feb 09 2016
    Edited Transcript of PSDV earnings conference call or presentation 8-Feb-16 9:30pm GMT Feb 09 2016
    PSivida reports 2Q loss Feb 08 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)